obstructive cardiomyopathy. Br Heart J 32: 691, 1970 In the absence of evidence for acute ischemia (angina and increased LV end-diastolic pressure), six patients had abnormal hemodynamic responses to the VM. Five had lack of systolic pressure overshoot and in one, systolic pressure did not decline during straining. When the VM was performed during an ischemic episode, 14 patients had abnormal responses (12 with lack of overshoot in phase IV and two with lack of systolic pressure decline in phase II). In 18 patients a prompt decline in LV end-diastolic pressure occurred with the disappearance of angina during the VM. These changes uniformly occurred during the latter part of straining (VM phase II) as cardiac size and systolic pressure declined. No adverse effects occurred when a VM was performed during acute ischemia.
SUMMARY The influence of the Valsalva maneuver (VM) on myocardial ischemia was evaluated in 24 patients with coronary heart disease. Clinical and hemodynamic responses to the VM were studied during acute ischemia manifested by angina pectoris with transient left ventricular (LV) dysfunction and compared with responses during nonischemic intervals.
In the absence of evidence for acute ischemia (angina and increased LV end-diastolic pressure), six patients had abnormal hemodynamic responses to the VM. Five had lack of systolic pressure overshoot and in one, systolic pressure did not decline during straining. When the VM was performed during an ischemic episode, 14 patients had abnormal responses (12 with lack of overshoot in phase IV and two with lack of systolic pressure decline in phase II). In 18 patients a prompt decline in LV end-diastolic pressure occurred with the disappearance of angina during the VM. These changes uniformly occurred during the latter part of straining (VM phase II) as cardiac size and systolic pressure declined. No adverse effects occurred when a VM was performed during acute ischemia.
Our observations suggest that the VM abruptly reduces determinants of cardiac oxygen demand, relieving acute ischemia without harmful effects.
STRAINING CAUSES exaggerated increases in intrathoracic pressure, frequently during various daily activities. The influence of maneuvers that increase intrathoracic pressure on myocardial ischemia has not been completely determined. For example, the Valsalva maneuver (VM) has been suggested as one of the few nonpharmacologic measures effective in relieving angina pectoris.' 2 The basis for this potentially beneficial response on manifestations of ischemia is not completely clear, and others have suggested that this maneuver may cause arrhythmias3 I and "bedpan deaths."5 These clinical associations were implied because of the important reduction of venous return that occurs during straining, result-ing in decreased aortic pressure and cardiac output. 6 Although direct measurements of coronary flow were not made, Gorlin and Storaasli7 concluded that the VM may reduce blood flow, since it increases the transcoronary circulation time. In a recent study, Benchimol and co-workers implied that the velocity of coronary flow was reduced in patients with and without coronary disease during straining.8 They estimated unidirectional velocity changes by the Doppler technique, and suggested that reduced flow velocity was secondary to reduced cardiac output and could predispose patients to potentially lethal arrhythmias. If so, improvement in myocardial oxygenation, implied by relief of clinical findings of acute ischemia, is difficult to interpret. Furthermore, the systolic pressure "overshoot" after a VM might induce angina or increase ischemia in some patients. Since this maneuver is performed so frequently, a better understanding of its effects on the coronary circulation may be important.
In the present investigation we studied left ventricular (LV) hemodynamic and clinical responses to a VM in patients with coronary artery disease during acute ischemia. Angina pectoris and a transient rise in LV end-diastolic pressure were considered evidence for ischemia. Emphasis was placed on hemodynamic 
Recordings and Calculations
Systemic, LV and RA pressures were recorded simultaneously from equisensitive Statham P23Db transducers on a multichannel recorder. Mean RAP was obtained by electronic filtration. Recordings were made continuously at 25 mm/sec throughout the maneuvers as described below. Pressures were measured from at least five consecutive beats during the phases outlined. Heart rate was calculated from a standard electrocardiographic lead. Changes in heart size were grossly estimated by a modification of the technique used by Sowton and co-workers.9 Briefly, cinefluoroscopy was performed before and during the VM (end of phases II and IV) in the posteroanterior projection. From the projected cardiac silhouette, the frontal plane cardiac area at end-diastole was measured. Because of patient-to-patient variation in magnification, the results were expressed as a percentage of change from the pre-VM determination.
Study Procedure
Patients were instructed to perform the "classic" VM as a maximal expiratory effort maintained against a closed glottis for 10-12 seconds. They did not try to achieve an arbitrarily set intrathoracic pressure, although all patients maintained at least a 35 mm Hg change in RAP. We observed control VM, performed in an ischemia-free interval, and a VM initiated during transient ischemia. The latter was manifested by angina pectoris associated with an abrupt abnormal increase in LV end-diastolic pressure in each patient. Nineteen of the 24 patients had an ischemic type ST-segment shift during the periods analyzed. These tests were performed as ischemia occurred spontaneously in 12 patients and was evoked by light leg exercise (unloaded bicycle ergometer) in 12 patients. After each VM performed during ischemia, patients were questioned regarding pain relief. Four patients who had used the VM for years to relieve angina, could also signal the precise period during the maneuver when relief began to occur.
Data were obtained from the following phases ( fig.  1 ) for each maneuver:10 Pre-VM -using 10 beats before each VM. Phase I -at the initial systolic pressure peak, immediately after the onset of straining. Phase II -during plateau, after systolic pressure declined just before release of straining. Phase IIIat the maximum systolic pressure decline, immediately after straining release. Phase IV -at the maximum rise or overshoot of systemic pressure after straining release. Post-VM -over the first minute after phase IV. Hemodynamic responses were judged abnormal if the phase IV systolic pressure overshoot was absent without reflex bradycardia or if systolic pressure failed to decline below the pre-Valsalva level during phase II.
After these studies each patient underwent selective coronary and LV angiography. All patients had . 75% diameter narrowing of at least one major coronary artery. Mean values and standard deviations for each hemodynamic variable were calculated during both the control and ischemic VM. An analysis of variance and t test were used, when appropriate, to examine the statistical significance of the comparisons made.
Results
VMs performed during spontaneous angina and stress-induced angina were not different in their clinical or hemodynamic results. Therefore, these data were considered together. Hemodynamic results are summarized in table 1.
Clinical Responses
The VM performed during ischemia evoked abnormal responses in 14 of 24 cases, compared with only six during the control VM. Examples of these responses are shown in figures 2-5. Absence of systolic pressure overshoot without bradycardia occurred in 12 of the 14 abnormal responses, five of which were present without transient ischemia. In the other two patients, systolic pressure failed to decline during the ischemic VM, while this response occurred in only one of these two patients during the control VM. Prompt, complete relief of angina resulted in 18 patients. Relief uniformly occurred during the latter part of phase II. One patient had complete relief when systolic pressure figure 3 .
Hemodynamic Responses
The hemodynamic changes we discuss refer to pre-VM and phase II data from control and ischemic periods, unless noted otherwise (table 1). in the magnitude of the VM-induced change in double product in phase II between the subgroup without relief compared to those with relief (11 and 13% decrease in phase II). Sufficient data were not available to compare VM effects on cardiac area in the subgroups because area was measured in only two patients without pain relief.
Discussion
The effects of the VM on hemodynamic and clinical responses related to myocardial ischemia are controversial. It has been suggested that a VM-induced increase in intrathoracic pressure may be both beneficial and deleterious. Support for the beneficial effects . originates from reports of relief of angina pectoris after the VM.1 2 The suggestion that it may be harmful derives from studies that implicate the maneuver in the production of bedpan deaths5 and arrhythmias.3 4 Thus, our study was undertaken to determine whether the VM alters either spontaneous or exercise-induced manifestations of ischemia in coronary artery disease patients.
Our results indicate that the VM promptly relieves acute episodes of myocardial ischemia in many of the patients studied, with no harmful effects. Clinical benefit was similar with either spontaneous or effortevoked angina. To explain relief of ischemia, hemodynamic responses during a VM performed in both ischemic and nonischemic periods were analyzed. The influence of the VM on ischemia-related increases in LV end-diastolic pressure supported the subjective angina responses suggesting that the VM relieves manifestations of ischemia. Abrupt end-diastolic pressure reduction was regularly noted during phase III (immediately after release of straining). The enddiastolic pressure did fall, in phase III and for several beats into phase IV, in some patients without relief of angina. However, within five to six beats after release of straining, end-diastolic pressure returned to values observed before straining in those who did not have relief. The VM-induced end-diastolic pressure decline persisted throughout phase IV and post-VM periods only in patients reporting relief of angina. Normal heart rate and systolic pressure responses to the VM did not appear to be prerequisites for VM-related improvement. Relief occurred in patients with both normal or abnormal hemodynamic responses. Furthermore, the VM systolic pressure "overshoot" did not induce or increase angina in any patient studied. Most patients observed that symptomatic improvement began during phase II (strain) as the increase in intrathoracic pressure was maintained.
The basis for this salutary effect on transient ischemia was seen in the hemodynamic factors influencing myocardial oxygen requirements and delivery. Important determinants of oxygen requirements include heart rate, myocardial tension and level of contractility. No significant heart rate slowing occurred, possibly indicating an abnormal baroreceptor response.11 With the VM-induced increase in intrathoracic pressure, LV dimensions are known to remain relatively constant for several beats,12 while developed pressure declines promptly (table 1) . Thus, pressure determinants of wall tension would be expected to decrease almost immediately. During continued straining, systolic and pulse pressures fall as the reduced venous return diminishes ventricular size. With continued increase in airway pressure (phase II), more striking decreases in developed pressure occur, so both pressure and volume determinants of myocardial wall tension decline. The heart rate-systolic pressure product also decreases during straininginduced reduction in venous return. Thus, increases in intrathoracic pressure suddenly reduce some hemodynamic determinants of cardiac oxygen demand. '3 When evaluating the influence of any agent on myocardial ischemia, one must consider the multiple factors contributing to the relationship of myocardial oxygen demand and supply. With the VM performed during ischemia there was a small increase in heart rate, moderate reduction in systolic pressure and small reduction in cardiac size. Heart size determinations from fluoroscopic tracings are crude estimates, and they were included only as a gross indicator of the directional change in size. During any maneuver that may change the geometry of the heart relative to the thorax, these estimates must be considered cautiously. Similar directional estimates of cardiac size have been reported by others during the VM.12 Since wall stress is the actual determinant of oxygen consumption, the volume factor is most important and will not be accounted for in the cardiac area or rate-pressure product. Nonetheless, diminished oxygen demand, resulting from VM-related reduction of venous return probably decreases oxygen requirements. This effect would be expected to result in a decrease in coronary flow dur- ing straining, and may explain some of the prior observations.7, 8 With respect to angina after the VM, comparison of the 18 patients who improved with the six who did not improve (fig. 6) showed that the unimproved patients probably required more oxygen delivery than the improved patients, as evidenced by higher heart rates and systolic pressures. Since no VM-related heart rate decrease occurred in patients with relief, the antianginal response to the VM must relate to other variables. The VM acts to reduce LV size through a reduction in venous return during either spontaneous or effort-evoked ischemia, and thus should reduce oxygen demands. We found lower LV diastolic and reduced systolic pressures in the improved patients, compared with the unimproved patients. This finding may be the result of a greater reduction in venous return and account for relative differences in the hemodynamic effects acting to alter more favorably the myocardial oxygen supply-demand relation. However, we could not be sure whether the decrease in end-diastolic and systolic pressure caused angina relief or resulted from relief by another mechanism.
We did not observe arrhythmias, syncope, dizziness, or other adverse effects. Furthermore, no changes occurred during the period of overshoot to suggest increased ischemia. That intolerance to this procedure was not encountered may relate to the improved hemodynamic function afforded by sudden alleviation of ischemia.
Our observations indicate that the VM promptly relieves manifestations of myocardial ischemia. These studies suggest that the physiologic basis for relief is unrelated to changes in heart rate. Hemodynamic alterations during straining appear to decrease determinants of myocardial tension, reducing cardiac oxygen requirements.
